Filtered By:
Specialty: Cardiology
Condition: Cardiomyopathy
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 533 results found since Jan 2013.
One ‐year results of the first‐in‐man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study
ConclusionsImplantation of the AFR device in HF patients was feasible. No shunt occlusion, stroke or new right HF was observed during the 1 ‐year follow‐up, with clinical improvements in certain patients.
Source: European Journal of Heart Failure - March 6, 2021 Category: Cardiology Authors: Christina Paitazoglou,
Martin W. Bergmann,
Ramazan Özdemir,
Roman Pfister,
Jozef Bartunek,
Teoman Kilic,
Alexander Lauten,
Alexander Schmeisser,
Mehdi Zoghi,
Stefan D. Anker,
Horst Sievert,
Felix Mahfoud,
AFR‐PRELIEVE Investigators Tags: Research Article Source Type: research
A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy
AbstractMicroRNAs (miRNAs) are small noncoding RNA molecules that act as major regulators of gene expression at the post-transcriptional level. As the potential applications of miRNAs in the diagnosis and treatment of human diseases have become more evident, many studies of hypertrophic cardiomyopathy (HCM) have focused on the systemic identification and quantification of miRNAs in biofluids and myocardial tissues. HCM is a hereditary cardiomyopathy caused by mutations in genes encoding proteins of the sarcomere. Despite overall improvements in survival, progression to heart failure, stroke, and sudden cardiac death remain...
Source: Heart Failure Reviews - March 3, 2021 Category: Cardiology Source Type: research
The prevalence, predictors, and outcomes of spontaneous echocardiographic contrast or left ventricular thrombus in patients with HFrEF
ConclusionsIn patients with HFrEF, SEC was not uncommon and increased risk of ischaemic stroke as well as LVT. Anticoagulants could play a role in the reduction of stroke risk, suggesting that patients with SEC/LVT, even those in sinus rhythm, would benefit from systemic anticoagulation treatment.
Source: ESC Heart Failure - January 26, 2021 Category: Cardiology Authors: Xiaodong Zhou,
Ruiyu Shi,
Gaojun Wu,
Qianli Zhu,
Changzuan Zhou,
Liangguo Wang,
Chenglong Xue,
Yuanyuan Jiang,
Xueli Cai,
Weijian Huang,
Peiren Shan Tags: Original Research Article Source Type: research
Fabry disease in cardiology: Diagnosis and therapeutic approaches
Turk Kardiyol Dern Ars. 2020 Dec;48(Suppl 2):1-42. doi: 10.5543/tkda.2020.38262.ABSTRACTFabry disease is a rare, progressive, X-linked inherited storage disorder due to absent or deficient of lysosomal alfa galactosidase A activity. Deficient activity of alfa-galactosidase A results in progressive accumulation of globotriaosylceramide in a variety of tissues and organs including myocardium, kidney and nerve system. This disorder predominantly affects males; however, female heterozygotes may also be affected with a less severe clinical picture. Classic Fabry disease is usually diagnosed in early age of childhood because of ...
Source: Turk Kardiyoloji Dernegi arsivi - January 21, 2021 Category: Cardiology Authors: Y üksel Çavuşoğlu Ebru Özpelit Nur Arslan Mesut Demir G ökhan Kahveci H üseyin Onay Emir Özgür Barış Ökçün Oma ç Tufekcioglu Selcen Yakar T ülüce Gonca K ılıç Yıldırım Source Type: research
